Therapeutic Asset Ratings

158 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
CIS-DIAMMINEDICHLOROPLATINUM II Squamous Cell Carcinoma Of Pancreas	Alliance for Clinical Trials in Oncology	P2/3	B (57)
Rucaparib Prostate Cancer	Alliance for Clinical Trials in Oncology	P3	B (56)
Tivozanib Stage III Renal Pelvis Cancer AJCC v8	Alliance for Clinical Trials in Oncology	P3	B (56)
Tivozanib Renal Pelvis Carcinoma	Alliance for Clinical Trials in Oncology	P3	B (56)
Rucaparib Castration-Resistant Prostate Carcinoma	Alliance for Clinical Trials in Oncology	P3	CCC (55)
Allopurinol B-Cell Acute Lymphoblastic Leukemia	Alliance for Clinical Trials in Oncology	P3	CCC (54)
Monosialotetrahexosylganglioside Breast Cancer	Alliance for Clinical Trials in Oncology	P3	CCC (54)
Abemaciclib CDK Gene Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Abemaciclib KRAS G12C Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Abemaciclib NTRK Family Gene Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Abemaciclib PI3K Gene Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Abemaciclib ROS1 Gene Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Adagrasib CDK Gene Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Adagrasib KRAS G12C Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Adagrasib Metastatic Malignant Neoplasm In The Brain	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Adagrasib NTRK Family Gene Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Adagrasib PI3K Gene Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Adagrasib ROS1 Gene Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Azacitidine Nodal T-Follicular Helper Cell Lymphoma, Follicular Type	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Entrectinib CDK Gene Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Entrectinib KRAS G12C Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Entrectinib Metastatic Malignant Neoplasm In The Brain	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Entrectinib NTRK Family Gene Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Entrectinib PI3K Gene Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)
Entrectinib ROS1 Gene Mutation	Alliance for Clinical Trials in Oncology	P2	CCC (53)

Showing 101 to 125 of 158 assets

PreviousPage 5 of 7Next